Schedule 13D ownership disclosure
INTEGRATED BIOPHARMA INC
Security class unavailable
Event date: 2023-03-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,581,509
- Percent of class
- 24.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-23-031869
- Form type
- SC 13D
- Filer
- INTEGRATED BIOPHARMA INC
- CIK
- CIK 1016504
- Filed
- Nov 14, 2023
- Reporting period
- Mar 20, 2023
- Description
- Schedule 13D beneficial ownership